Is SBRA's Q1 2025 EPS forecast signaling growth continuation?

**Sabra Health Care REIT (SBRA) is not currently forming a bullish signal for the Q1 2025 EPS forecast.** Here's an analysis based on the available data:

1. **Recent Analyst Upgrades and Price Targets**: JMP Securities upgraded SBRA from Market Perform to Market Outperform on January 7, 2025, indicating a positive outlook. The average one-year price target as of December 23, 2024, suggests a 20.32% upside potential. This suggests that analysts are expecting growth in SBRA's stock price, which could be indicative of continued growth in earnings per share (EPS).

|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|SBRA|SBRA.O|Sabra Health Care|2024 Q2|11.111111111111121|0.1|185|
|SBRA|SBRA.O|Sabra Health Care|2024 Q3|285.7142857142857|0.13|185|

2. **Historical Performance and Estimates**: SBRA has beaten its EPS estimate 0.00% of the time in the past 12 months, while its overall industry has beaten EPS estimates 53.70% of the time in the same period. This indicates that SBRA has underperformed its industry in terms of EPS consistency, which does not necessarily signal growth continuation.
3. **Q4 2024 Results**: SBRA reported quarterly adjusted earnings of 19 cents per share for the quarter ended December 31, 2024, which is higher than the same quarter last year's EPS of 7 cents. This is a positive indicator of growth continuation, as the company has shown an improvement in EPS over the past year.
4. **Market Sentiment and Forecasts**: The current average analyst rating on SBRA shares is "buy," with a consensus recommendation for the specialized REIT peer group also being "buy". This positive sentiment among analysts could suggest that the Q1 2025 EPS forecast is signaling growth continuation.

In conclusion, while the historical performance of SBRA in beating EPS estimates is not strong, the recent analyst upgrades, the improvement in EPS from the previous year, and the positive market sentiment suggest that SBRA's Q1 2025 EPS forecast could be signaling growth continuation. However, it's important to note that the lack of available data for Q1 2025 EPS makes it difficult to provide a definitive conclusion.